Patients with heart failure, peripheral artery disease or stroke could benefit from a new stem-cell based treatment, following an agreement with US-based AngioStem Inc.
The University of Queensland (UQ) and Pfizer today launched a new partnership to help advance new drug discovery in Australia.
Redback Technologies and UniQuest have signed a Memorandum of Understanding aimed at accelerating the development of the company's energy storage technology.
An international collaboration to discover and develop new therapeutic drugs is set to find new treatments for Ross River virus.
A new international collaboration is set to uncover ground-breaking therapeutic-based discoveries and help progress them to the next crucial stage in their development.
A message from Professor Peter Høj, discussing research translation and commercialisation.
More cancer patients will now have access to early lymphedema detection technology, with a product developed by publicly listed medical device company Impedimed Limited (
In 2014, Protagonist Therapeutics, Inc.
QUE Oncology, Inc. is developing novel therapies to address unmet medical needs in the treatment of cancer and its consequences.
Pharmaceutical company AstraZeneca and UniQuest have formed an "open innovation" program to support academic and clinical research that holds the promise of fin
UniQuest Pty Ltd
Level 7, General Purpose South Building (Building 78)
Staff House Road
The University of Queensland
Brisbane, Queensland 4072
+61(0)7 3365 4037
The main commercialisation company of
© Copyright 2014 UniQuest
ABN 19 010 529 898